However, the weak second quarter highlights how quickly earnings can fall when inventory losses rise, prices move against the ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...

Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...

Eli Lilly and Company (NYSE: LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

Eli Lilly and Co. LLY on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...

US drugmaker Eli Lilly has announced positive topline results from the landmark TOGETHER-PsO open-label Phase IIIb trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline results announced by Eli ...

Councillors vote to end the local authority's subsidy of flights between Newquay and Gatwick.

Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for ...

Many of the professionals associated with Freiburg weren’t involved in the 2022 DFB Pokal Final shootout at Berlin’s Olympiastadion. That didn’t necessarily mean there wasn’t a sense of deja ...